Incheon, South Korea

Jun Yong Park


 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Antibody Preparation by Jun Yong Park

Introduction

Jun Yong Park is a dedicated inventor based in Incheon, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the preparation and regulation of antibodies. With a unique method that enhances the quality of antibodies, Park plays a vital role at Prestige Biopharma Pte. Ltd.

Latest Patents

Park holds a patent for a groundbreaking method titled "Method for preparing antibody through regulation of sugar content of antibody." This innovative process involves culturing antibody-expressing cells in a medium supplemented with glycerol to effectively regulate the sugar chain content of antibodies. The method provides a high-quality population of antibodies by fine-tuning this sugar content, which is crucial for developing biosimilars that closely mimic control drugs. The efficiency of this preparation method emphasizes its potential for widespread application in antibody research and development.

Career Highlights

At Prestige Biopharma Pte. Ltd., Jun Yong Park has become instrumental in advancing the company's capabilities in biopharmaceuticals. His work not only enhances the quality of antibodies but also improves the efficiency of the preparation process, ensuring cost-effectiveness and time-saving solutions in the development of therapeutic antibodies.

Collaborations

Park collaborates with esteemed colleagues, including Jae Young Chang and Eun Ho Hwang, contributing to an innovative environment focused on groundbreaking research and development in biopharmaceuticals. Together, they strive to push the boundaries of what is possible in medicine and drug development.

Conclusion

Jun Yong Park's contributions to the field of antibody preparation are noteworthy and demonstrate the pivotal role of innovation in biopharmaceuticals. His patented method not only provides a pathway for higher quality antibody populations but also showcases the potential for efficient regulatory methods in this vital sector of healthcare. As the industry evolves, Park's advancements will continue to pave the way for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…